Ray KK, Seshasai SRK, Wijesuriya S et al
Funding This study was supported by Natural Science Foundation of Guangdong Province (2021A1515012393), NSFC grant (82371692, 32170825), Key laboratory of functional and clinical translational medicine, Guangdong Provincial Sports Bureau Scientific Research Project (GDSS2024N007), and Guangdong Medical Science and Technology Research Foundation (A2023145)
Mild restlessness and insomnia have been reported, particularly when taken later in the day [5][7]
Another 2024 study, involving more than 400,000 patients in the Netherlands, found that people with Type 2 diabetes who used semaglutide had more than double the risk of developing NAION compared to those who didnt take the drug
2014 Liraglutide, Saxenda markasyla obezite tedavisi iin FDA onay alan ilk GLP-1 ilac oldu